Related references
Note: Only part of the references are listed.Oxidative damage in synovial tissue is associated with in vivo hypoxic status in the arthritic joint
Monika Biniecka et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Effect of adalimumab on joint disease: features of patients with psoriatic arthritis detected by magnetic resonance imaging
A. P. Anandarajah et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Impact of T-cell costimulation modulation in patients with undifferentiated inflammatory arthritis or very early rheumatoid arthritis: a clinical and imaging study of abatacept (the ADJUST trial)
P. Emery et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Synovial tissue hypoxia and inflammation in vivo
C. T. Ng et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Angiogenesis and Blood Vessel Stability in Inflammatory Arthritis
Aisling Kennedy et al.
ARTHRITIS AND RHEUMATISM (2010)
Hypoxia Activates NF-κB-Dependent Gene Expression Through the Canonical Signaling Pathway
Kathryn M. Oliver et al.
ANTIOXIDANTS & REDOX SIGNALING (2009)
Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis
John M. L. Ebos et al.
CANCER CELL (2009)
Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
Marta Paez-Ribes et al.
CANCER CELL (2009)
Synovial Tissue Sublining CD68 Expression Is a Biomarker of Therapeutic Response in Rheumatoid Arthritis Clinical Trials: Consistency Across Centers
Barry Bresnihan et al.
JOURNAL OF RHEUMATOLOGY (2009)
Immature Blood Vessels in Rheumatoid Synovium Are Selectively Depleted in Response to Anti-TNF Therapy
Elena Izquierdo et al.
PLOS ONE (2009)
Hypoxia upregulates angiogenesis and synovial cell migration in rheumatoid arthritis
Mohammed A. Akhavani et al.
ARTHRITIS RESEARCH & THERAPY (2009)
Synovial hypoxia as a cause of tendon rupture in rheumatoid arthritis
Branavan Sivakumar et al.
JOURNAL OF HAND SURGERY-AMERICAN VOLUME (2008)
Role of hypoxia-inducible factor-1α in hypoxia-induced expressions of IL-8, MMP-1 and MMP-3 in rheumatoid fibroblast-like synoviocytes
J. K. Ahn et al.
RHEUMATOLOGY (2008)
Therapeutic T-cell manipulation in rheumatoid arthritis: past, present and future
J. D. Isaacs
RHEUMATOLOGY (2008)
Target practice: Lessons from phase III trials with bevacizumab and vatalanib in the treatment of advanced colorectal cancer
Maartje Los et al.
ONCOLOGIST (2007)
Detailed analysis of the cell infiltrate and the expression of mediators of synovial inflammation and joint destruction in the synovium of patients with psoriatic arthritis: implications for treatment
A. W. R. van Kuijk et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug-induced clinical remission - Evidence from an imaging study may explain structural progression
A. K. Brown et al.
ARTHRITIS AND RHEUMATISM (2006)
Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy - Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks
Stanley B. Cohen et al.
ARTHRITIS AND RHEUMATISM (2006)
Classification criteria for psoriatic arthritis - Development of new criteria from a large international study
William Taylor et al.
ARTHRITIS AND RHEUMATISM (2006)
The validation of simple scoring methods for evaluating compartment-specific synovitis detected by MRI in knee osteoarthritis
LA Rhodes et al.
RHEUMATOLOGY (2005)
Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis
JJ Haringman et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy
RK Jain
SCIENCE (2005)
T cells, fibroblast-like synoviocytes, and granzyme B plus cytotoxic cells are associated with joint damage in patients with recent onset rheumatoid arthritis
MC Kraan et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
Reduction of synovial sublining layer inflammation and proinflammatory cytokine expression in psoriatic arthritis treated with methotrexate
D Kane et al.
ARTHRITIS AND RHEUMATISM (2004)
Tumor necrosis factor a blockade reduces the synovial cell infiltrate early after initiation of treatment, but apparently not by induction of apoptosis in synovial tissue
TJM Smeets et al.
ARTHRITIS AND RHEUMATISM (2003)
Adalimumab, a fully human anti-tumor necrosis factor a monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate - The ARMADA trial
ME Weinblatt et al.
ARTHRITIS AND RHEUMATISM (2003)
Hypoxia-induced production of stromal cell-derived factor 1 (CXCL12) and vascular endothelial growth factor by synovial fibroblasts
C Hitchon et al.
ARTHRITIS AND RHEUMATISM (2002)
Angiogenesis in the pathogenesis of inflammatory joint and lung diseases
DA Walsh et al.
ARTHRITIS RESEARCH (2001)
Infliximab and methotrexate in the treatment of rheumatoid arthritis
PE Lipsky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
